
In this episode of Rethink Imaging, host Chris St. John sits down with Dr. Kalpana Kanal and Dr. Thomas Griglock to discuss the newly updated Diagnostic Reference Levels (DRLs) and Achievable Doses (ADs) published ten years after the benchmark 2014 study. Analyzing a massive dataset of 5.2 million CT exams from 2025, they break down the 22% reduction in national DRLs, explain why low dose isn't always good dose, and emphasize why clinical optimization and diagnostic image quality must take precedence over endless dose reduction.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Why the “Average Patient” Can’t Exist in Medical Imaging | Dr. Ehsan Samei

Radiology Can't Keep Up. Here's Where AI Actually Helps | Dr. Nina Kottler

Where MRI Safety Standards Still Fall Short, and How to Fix Them with Tobias Gilk

The MRI Safety Myth: “No Radiation” Doesn’t Mean No Risk with Tobias Gilk
Free AI-powered recaps of Rethink Imaging and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.